We should, however, avoid the medical convention whereby each product is either over-the-counter or prescription, regardless of who is buying the product. In order to keep the system lean, there should be a provision for exempting some individuals and firms – those sophisticated enough to handle their own affairs, or well off enough to deal with financial failure – from the requirement of an RFP’s approval before buying a prescription financial product.